Tandem’s t:Slim X2 insulin pumpThe U.S. Food and Drug Administration (FDA) has approved the t:slim X2 insulin pump with Basal-IQ technology from Tandem Diabetes Care. Basal-IQ is a predictive low glucose suspend (PLGS) feature designed to help reduce the frequency and duration read more »

Tandem Diabetes Care, the medical device company and manufacturer of the only touchscreen insulin pumps available in the US has entered into a distribution agreement with Rubin Medical to commercialize its t:slim X insulin pump (and supplies) in Sweden, Norway and Denmark. read more »